Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2012
03/20/2012US8138177 Benzimidazolone derivatives as CB2 receptor ligands
03/20/2012US8138173 Pyrazolo[3,4-C]quinolines, pyrazolo[3,4-C]naphthyridines, analogs thereof, and methods
03/20/2012CA2656507C Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors
03/20/2012CA2628131C Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
03/20/2012CA2579840C Carboxamide spirolactam cgrp receptor antagonists
03/20/2012CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis
03/20/2012CA2493225C Quinoline derivatives and their use as mycobacterial inhibitors
03/20/2012CA2405076C Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
03/20/2012CA2396277C Condensed azepines as vasopressin agonists
03/20/2012CA2363067C Compounds and methods to inhibit or augment an inflammatory response
03/15/2012WO2012034091A1 Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors
03/15/2012WO2012033548A2 Herbicidal bis-nitrogen-containing oxo and sulfono heterocycles
03/15/2012WO2012033149A1 Hetero ring-fused imidazole derivative having ampk activating effect
03/15/2012WO2012033144A1 Pyrazoloquinoline compound
03/15/2012WO2012032990A1 Photoelectric conversion material, film containing material, photoelectric conversion element, method for producing photoelectric conversion element, method of using photoelectric conversion element, photosensor and image sensor
03/15/2012WO2012032334A1 Quinoline and quinoxaline derivatives as kinase inhibitors
03/15/2012WO2011139242A3 Process for the preparation of 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole derivatives
03/15/2012US20120065402 Electronic device including phenanthroline derivative
03/15/2012US20120065227 TRIAZOLOPYRIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
03/15/2012US20120065225 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof
03/15/2012US20120065224 Pyrrolo[3,2-c) pyridine derivatives and processes for the preparation thereof
03/15/2012US20120065211 Alkoxy tetrahydro-pyridopyrimidine pde10 inhibitors
03/15/2012US20120065189 Heterocyclic compounds for the treatment of stress-related conditions
03/15/2012US20120065185 Substituted alkylamine derivatives and methods of use
03/15/2012US20120065183 Tetrahydro-Pyrido-Pyrimidine Derivatives
03/15/2012US20120064181 P2X3 Receptor Antagonists for Treatment of Pain
03/15/2012CA2811025A1 Hetero ring-fused imidazole derivative having ampk activating effect
03/15/2012CA2810858A1 Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors
03/15/2012CA2810696A1 Pyrazoloquinoline compound
03/15/2012CA2808959A1 Quinoline and quinoxaline derivatives as kinase inhibitors
03/14/2012EP2428508A1 Diamino heterocyclic carboxamide compound
03/14/2012EP2427465A1 Substituted spirocyclic amines useful as antidiabetic compounds
03/14/2012EP2427464A1 Pyrazolopyridines
03/14/2012EP2427463A1 Imidazo [1, 2 -a] pyridin-2 -yl-phenyl derivatives to be used in cancer treatment
03/14/2012EP2427462A1 Pyrrolo [2, 3. b]pyridines which inhibit raf protein kinase
03/14/2012EP2427461A1 3-(ý1,2,3¨triazole-4-yl)-pyrroloý2,3-b¨pyridine derivates
03/14/2012EP2427454A1 Phenoxymethyl heterocyclic compounds
03/14/2012EP2427453A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
03/14/2012EP2427450A1 Gpr 119 modulators
03/14/2012EP2427448A1 Gpr 119 modulators
03/14/2012EP2427437A1 Dihydropyrimidinones for use as bace2 inhibitors
03/14/2012EP2427433A1 Solid forms of sulfonamides and amino acids
03/14/2012EP2427193A1 Use of pde7 inhibitors for the treatment of movement disorders
03/14/2012EP2321319B1 Antiviral compounds
03/14/2012EP2086975B1 7,8-dihydro-1,6-naphthyridin-5(6h)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase iv and methods
03/14/2012EP1971608B1 Spiroketals
03/14/2012EP1667685B1 Quinazoline potassium channel inhibitors
03/14/2012EP1474420B1 Quinazoline compounds
03/14/2012CN102372712A Imidazodiazanaphthalene PI3K (phosphatidyl inositol 3 kinase) and mTOR (mammalian target of rapamycin) dual inhibitor
03/14/2012CN102372711A Imidazo quinoline PI3K and mTOR (mammalian target of rapamycin) dual inhibitor
03/14/2012CN102372710A Fused cyclic compound being taken as mineral corticoid recept antagonist
03/14/2012CN102372709A Aryl phenanthroline compound and application thereof
03/14/2012CN102372708A Pyridyl phenanthroline compound and application
03/14/2012CN102372707A Synthetic method of 6-methyl-4-bromine-1,6-dihydropyrrole[2,3-c]pyridine-7-one
03/14/2012CN102372706A Phthalazinone derivative, its preparation method and application in medicament
03/14/2012CN102372698A Phthalazinone derivative and its preparation method and use in medicine
03/14/2012CN101426790B Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
03/14/2012CN101291933B Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
03/14/2012CN101001858B S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor
03/13/2012US8134015 Compound inhibiting in vivo phosphorous transport and medicine containing the same
03/13/2012US8134001 Spiroindolinone derivatives
03/13/2012US8133997 2,4-dioxopyrimidine-based mesoionic pigments
03/13/2012US8133992 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
03/13/2012US8133902 Ammosamides as anticancer agents
03/13/2012US8133898 Renin inhibitors
03/13/2012US8133896 Pyrimidine derivatives which are antagonist of the vitronectin receptor
03/13/2012US8133893 Trazodone and trazodone hydrochloride in purified form
03/13/2012US8133885 Non steroidal glucocorticoid receptor modulators
03/13/2012US8133847 Pyrido[2,3-B]pyrazine derivatives useful as herbicidal compounds
03/13/2012US8133473 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
03/13/2012CA2530444C Tricyclic .delta. opioid modulators
03/08/2012WO2012031197A1 Novel compounds and compositions for the inhibition of nampt
03/08/2012WO2012031196A1 4- { [ ( pyridin- 3 - yl -methyl) aminocarbonyl] amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
03/08/2012WO2012031140A1 Adsorption of immunopotentiators to insoluble metal salts
03/08/2012WO2012030145A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
03/08/2012WO2012030106A2 Production method of intermediate compound for synthesizing medicament
03/08/2012WO2012029991A1 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
03/08/2012WO2012029544A1 Organic semiconductor particulate material, organic semiconductor thin-film, dispersion liquid for forming organic semiconductor film, method for producing organic semiconductor thin-film, and organic thin-film transistor
03/08/2012WO2012029070A1 Heterocyclyl compounds as histamine h3 receptor ligands
03/08/2012WO2012028756A1 Preparation of substituted pyrido[2,3-d]pyrimidin-7(8h)-one compounds
03/08/2012WO2012028647A1 Bicyclic aza heterocycles, and use thereof
03/08/2012WO2012028645A1 Method for the production of 5-fluoro-1h-pyrazolo[3,4-b]pyridine-3-carbonitrile
03/08/2012WO2012028582A1 Herbicidally active ketosultams and diketopyridines
03/08/2012WO2012028233A1 Imidazo[4,5-c]quinolines as dna-pk inhibitors
03/08/2012WO2012028106A1 Deuterium-enriched heterocyclic compounds as kinase inhibitors
03/08/2012WO2012027960A1 Quinazoline derivatives substituted by aniline, preparation method and use thereof
03/08/2012WO2012007869A3 N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
03/08/2012WO2012003912A8 Bipyridyl derivatives useful for the treatment of kinase - induced diseases
03/08/2012US20120059168 Naphthalenetetracarboxylic acid derivatives and their use as semiconductors
03/08/2012US20120059030 Heterocyclic compound and use thereof
03/08/2012US20120059019 Compounds for the Treatment of Hepatitis C
03/08/2012US20120059002 Novel anti-inflammatory agents
03/08/2012US20120059001 Novel kinase modulators
03/08/2012US20120058989 Antibacterial fluoroquinolone analogs
03/08/2012US20120058940 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
03/08/2012US20120058939 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
03/08/2012US20120058893 Herbicidally active ketosultams and diketopyridines
03/08/2012US20120058892 N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and their use as herbicides
03/08/2012DE102010040234A1 Verfahren zur Herstellung von 5-Flour-1H-pyrazolo[3,4-b]pyridin-3-carbonitril Process for the preparation of 5-Flour-1H-pyrazolo [3,4-b] pyridine-3-carbonitrile
03/08/2012CA2812970A1 Heterocyclyl compounds as histamine h3 receptor ligands